The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001441:Bacteroides fragilis / Q000187:drug effects; D002440:Cefoxitin / Q000494:pharmacology*; D004347:Drug Interactions; D004755:Enterobacteriaceae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; D002440:Cefoxitin